BMO
LLY icon

Beck Mack & Oliver’s Eli Lilly LLY Stock Holding History

Beck Mack & Oliver’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,669
Closed -$306K – 340
2015
Q2 		$306K Hold
3,669
– – 0.01% 272
2015
Q1 		$267K Sell
3,669
-75
-2% -$5.34K 0.01% 299
2014
Q4 		$258K Sell
3,744
-100
-3% -$6.75K 0.01% 304
2014
Q3 		$249K Sell
3,844
-2,257
-37% -$143K 0.01% 311
2014
Q2 		$379K Sell
6,101
-214
-3% -$12.8K 0.01% 269
2014
Q1 		$372K Sell
6,315
-483
-7% -$27K 0.01% 257
2013
Q4 		$347K Buy
6,798
+583
+9% +$29.2K 0.01% 271
2013
Q3 		$313K Sell
6,215
-170
-3% -$8.9K 0.01% 271
2013
Q2 		$314K Buy
+6,385
New +$347K 0.01% 270

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Beck Mack & Oliver's LLY Position: Q3 2015 in Review

Beck Mack & Oliver sold out of Eli Lilly (LLY) in Q3 2015, closing a stake of 3,669 shares — an estimated $306K sold.

Beck Mack & Oliver first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $379K in Q2 2014. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • Beck Mack & Oliver reported no remaining Eli Lilly position as of Q3 2015 after selling out during the quarter.
  • Beck Mack & Oliver sold 3,669 Eli Lilly shares in Q3 2015, an estimated $306K.
  • Beck Mack & Oliver first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
  • Beck Mack & Oliver's Eli Lilly position peaked at $379K in Q2 2014.
  • 1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Beck Mack & Oliver's 13F filing for Q3 2015, filed 2 Nov 2015.